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Human rhinovirus (HRV) is an emerging viral pathogen.
Aim: To characterize a group of patients admitted due to infection by this agent in a general
hospital in Chile.
Methods: Cases were identiﬁed by RT-PCR for 1 year through active surveillance of patients
admitted with severe respiratory illness. Diagnosis was not available during hospitaliza-
tion.  Thirty-two cases were identiﬁed, 90% were ≥60 years old or had co-morbid conditions.
Human rhinovirus-related admissions represented 23.7% of hospitalization due to severe
acute respiratory infections among adults and ranked second to inﬂuenza (37.8%). Patients
presented with pneumonia (68.8%), decompensated chronic lung conditions (21.9%), heart
failure or inﬂuenza-like illness (6.3% each). Admission to intensive or intermediate care units
was required by 31.2% and in-hospital mortality reached 12.5%. A CURB-65 score ≥3 was
signiﬁcantly associated to in-hospital mortality (p < 0.05). Most patients received antibiotics
(90%).
Conclusions: Human rhinovirus infections in elderly patients with co-morbid conditions areassociated with hospitalizations, requiring critical or semi-critical antibiotics use. A high
CURB-65 score was associated to in-hospital mortality.
© 2014 Elsevier Editora Ltda. All rights reserved.
pitalizations, mortality, and inappropriate antibiotic use.IntroductionUpper and lower viral respiratory infections represent an
important global health burden for adult patients due to
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1413-8670/© 2014 Elsevier Editora Ltda. All rights reserved.their morbidity, absenteeism, outpatient medical visits, hos-
1–9dicina, Hospital Militar de Santiago, Av. Alcalde Fernando Castillo
Human rhinovirus is one of the etiological agents involved
in acute respiratory infections and has been associated with
crisis of asthma, exacerbated chronic bronchitis, bronchiolitis
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Clinical  manifestations
Most patients were admitted under the diagnosis of
community-acquired pneumonia, followed by chronic
8
6
Fr
eq
ue
nc
y
4
2
0
1 2 3 4 5 6 7
Month
 8 9 10 11 12b r a z j i n f e c t d i s .
nd pneumonia in children.10 Nonetheless, its role in adult
atients is less accepted despite progressive evidence of its
mportance in outpatient clinical settings4,11,12 or in hospital-
zed or immunosuppressed patients.13,14 This unrecognized
ole is changing after the recent availability of molecular diag-
ostic testing that has enhanced our knowledge on this viral
gent.2,3,15,16
In this work we report seasonality, clinical features and out-
omes of adult patients hospitalized during 1 year for severe
espiratory acute infection secondary to human rhinovirus
nfection in a general hospital.
atients  and  methods
tudy  design  and  setting
he Hospital Militar of Santiago is one of the six active surveil-
ance centers for acute severe respiratory infections requiring
dmission, a system launched in July 2011 by the Pan Ameri-
an Health Organization (PAHO) and the Chilean Ministry of
ealth after the inﬂuenza A (H1N1) pandemic to recognize
ew respiratory viral threats. It attends active and retired mili-
ary personnel and their relatives. The average age of admitted
atients is 76 years.
This was a prospective descriptive study that included all
dult patients ≥18 years admitted due to severe acute respi-
atory infection (SARI) associated with a conﬁrmed human
hinovirus detection obtained from respiratory samples dur-
ng the year 2012 (see below). SARI was deﬁned by the presence
f fever and respiratory symptoms associated either with
achypnea (≥30 min–1) or a low digital pulse oxymetry (<90%)
t room air.17 All patients fulﬁlling these criteria were reported
n-line to a centralized surveillance system and nasopha-
yngeal swab samples are assessed, at local level, for the
resence of inﬂuenza A-B, respiratory syncytial virus, parain-
uenza 1, 2, and 3, adenovirus and human metapneumovirus
y indirect immunoﬂuorescence using commercial reagents.
nﬂuenza A or B positive samples as well as all negative sam-
les were referred to a reference laboratory (Instituto de Salud
ública: ISP) for further analyses using molecular techniques.
nﬂuenza virus was tested and sub typed with the molec-
lar kit FluRUO-01, and non-inﬂuenza respiratory viruses
sing kit KK0812, provided by the CDC. The latter allows
etection by PCR of adenovirus, respiratory syncytial virus,
uman metapneumovirus, parainﬂuenza 1, 2, and 3, as well
s rhinovirus (HRV), not included in the initial immunoﬂu-
rescence panel.18 For nucleic acid extraction we  used the
utomated Easy Mag system from Biomerieux. Ampliﬁcation
as performed using Ag Path –ID kits from Ambion and a
eal time thermo cycler (Applied Biosystems). The results of
 positive HRV detection were not available during hospital-
zation.
Cases were analyzed according to demographic infor-
ation, seasonality, comorbidities, clinical presentation
ncluding chest X-ray, PaFiO2, and outcome at the moment of
ischarge. Some topics were collected prospectively (demo-
raphics, comorbidities, vaccine history, tobacco smoking,
lace of hospitalization) and other retrospectively (clinical
resentation and symptoms, laboratory data, management,5;1 9(2):118–124 119
severity score and outcome). Respiratory failure was deﬁned
as a PaFiO2 < 300 and graded.19,20
Statistical  analysis
Results are shown is a descriptive manner. Factors associ-
ated to mortality were identiﬁed calculating odds ratios (OR)
with their respective conﬁdence intervals. Two severity scores
(CURB-65 and CAP-PIRO) were calculated and compared to pre-
dict in-hospital mortality.21,22
Results
Thirty-two conﬁrmed patients, each with a single severe
episode of HRV infection were admitted during 2012. Cases
presented a seasonal pattern along the year but were detected
continuously during 8 months from March to October (sum-
mer  to spring in southern hemisphere) (Fig. 1). Of 135 adult
patients admitted with SARI during year 2012 with a conﬁrmed
viral etiology, HRV ranked second only to inﬂuenza infections
(23.7% versus 37.8% for inﬂuenza).
Mean age was elevated (79.5 years) and 90% were older
than 60 years (Table 1). Only two patients lived in a long-
term care facility, but near 20% were bedridden. Over 50% of
the patients had two or more  comorbidities, mainly chronic
pulmonary conditions, heart disease, diabetes mellitus, or
neurologic diseases. Cancer, morbid obesity, or kidney dis-
ease were not common. No case was associated with chronic
liver disease and only one patient was immunosuppressed.
Previous tobacco smoking affected near a third of this popu-
lation and current smoking was still admitted by two out of
32 patients. Almost one-third of patients with chronic lung
disease were domiciliary oxygen users (Table 1).Fig. 1 – Monthly distribution of 32 patients admitted with
human rhinovirus-associated severe acute respiratory
infection during one year at a general hospital in Chile.
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Table 1 – Features of 32 patients admitted with SARI
associated with human rhinovirus.
Variable Results
Age in years, mean (range) 79.5 (49–95)
Age ≥60 years, n (%) 31 (90%)
Female, n (%) 17 (53.1%)
Bedridden, n (%) 6 (18.8%)
Long-term care facility, n (%) 2 (6.3%)
Previous tobacco smoking, n (%) 9  (28.1%)
Current tobacco smoking, n (%) 2 (6.3%)
Asthma/COPD/lung ﬁbrosis, n (%) 17  (53.1%)
Domiciliary oxygen user, n (%) 5 (15.6%)
Cerebrovascular disease/dementia n (%) 10 (31.3%)
Diabetes mellitus n (%) 10 (31.3%)
Heart disease n (%) 11 (34.4%)
Kidney disease n (%) 3 (9.4%)
Morbid obesity n (%) 2 (6.3%)
Malignancies, n (%) 3 (9.4%)
Immunosuppresion, n (%) 1 (3.1%)
Any comorbidity, n (%) 30 (93.8%)
Table 3 – Medical consultations and physical and
laboratory parameters at admission among 32 patients
with human rhinovirus-associated respiratory infection
during year 2012.
Variable Results
Consultations before admission
0–1 29 (90.6%)
>1 3 (9.4%)
Days with symptoms before
hospitalization mean (range)
3  (1–21)
Temperature ◦C, mean (range) 37.2 (36.0–40.0)
Temperature < 37 ◦C, n (%) 16 (50%)
Respiratory rate/min, mean (range) 27.1 (18–40)
Respiratory rate ≥30/min, n (%) 13 (40.6%)
Heart rate/min, mean (range) 98.3 (55–131)
O2 pulse digital oxymetry %, mean (range) 85.1 (67–95)
O2 Saturation <90%, n (%) 25 (78.1%)
PaO2 at admission mmHg, mean (range) 58.8 (39.5–78.3)
PaO2 <60 mmHg, n (%) 16 (50.0%)
PaFiO2, mean (range) 239.4 (78–367)
PaFiO2 <300, n (%) 22 (78.6%)*
PaFiO2 200–299, n (%) 15 (53.6%)*
PaFiO2 100–199, n (%) 6 (21.4%)*
PaFiO2 <100, n (%) 1 (3.6%)*
Blood leukocyte count/L, mean (range) 12012 (4800–27200)
Leucocytosis >12,000/L  13 (40.6%)
Leucocytosis >15,000/L  8 (25.0%)
Blood polymorphonuclear count/L, mean
(range)
9984 (3860–25910)
Neutrophilia >8000/L 19 (59.4%)
Neutrophilia >12,000/L  12 (37.5%)
Lymphocyte count/L, mean (range) 1225.8 (180–7750)
Lymphocyte count <1000/L, n (%) 19 (59.4%)
Erythrocyte sedimentation rate mm/h,
mean (range)
42.6  (2–106)One comorbidity n (%) 12 (37.5%)
≥ 2 comorbidities, n (%) 18 (56.3%)
obstructive pulmonary disease (COPD) exacerbations or
other conditions (Table 2). Symptoms in descending order
of frequency were cough and sputum, fever in nearly half
of cases, and confusion/disorientation (Table 2). The latter
manifestation was strongly associated with previous neuro-
logical disease. Seven out of 10 patients with a neurological
condition presented disorientation or confusion compared
with two out of 22 without this comorbidity (OR 23.2; 95%
CI 3.2–169, p < 0.01). Classic upper respiratory symptoms
such as headache, rhinorrhea, and odynophagia were less
frequent (<25%). No patients presented diarrhea, and only two
developed nauseas or abdominal pain. Bronchial obstructive
signs were common (∼60%), a ﬁnding associated with chronic
Table 2 – Clinical manifestations among 32 patients
admitted with human rhinovirus-associated severe
respiratory infection during year 2012.
Variable, n (%) Results
Clinical presentation
Community-acquired pneumonia 22 (68.8%)
COPD exacerbation 5 (15.6%)
Decompensated lung ﬁbrosis 2 (6.3%)
Decompensated chronic heart failure 2 (6.3%)
Inﬂuenza-like illness 1 (3.1%)
CURB-65 score
< 2 14 (43.8)
≥ 2 18 (56.3%)
Cough 32 (100%)
Sputum 26 (81.3%)
Fever 14 (43.8%)
Confusion/disorientation 9 (28.1%)
Rhinorrhea 7 (21.9%)
Myalgia 4 (12.5%)
Odynophagia 2 (6.3%)
Headache 2 (6.3%)
Nausea/abdominal pain 2 (6.3%)
Hypotension 7 (21.9%)
Bronchial obstructive signs 19 (59.4%)
Plasma sodium concentration mEq/L,
mean (range)
138.4  (120–150)
Hyponatremia (plasma sodium <135 mEq/L) 4 (12.5%)
LDH in plasma U/L mean (range) 232.1 (117–468)
Blood urea nitrogen mg/dL mean (range) 25 (7–77)
C-reactive protein mg/L, mean (range) 122.8 (7.2–494)
C-reactive protein ≥100 mg/L, n (%) 15 (46.9%)∗ of 28 patients with available information.
lung disease (OR 20.7; 95% CI 3.2–133, p < 0.01), or previous
or current tobacco consumption (OR 24.4; 95% CI 1.3–469,
p < 0.01). Hypotension was present in one ﬁfth of patients at
admission.
Symptoms evolved between one and 21 days before admis-
sion (average ﬁve, mean three days) and 90% presented
symptoms for less than seven days before hospitalization.
Nearly two-thirds of these patients were hospitalized at ﬁrst
consultation (Table 2).
Some physical and laboratory ﬁndings are shown in Table 3.
As part of the severe respiratory infection deﬁnition used
in this work, most patients presented with tachypnea, low
O2 saturation, or respiratory failure (PaFiO2 < 300; 25% with
a PaFiO2 < 200) but only half had fever. Leukocytosis, neu-
trophilia, elevated erythrocyte sedimentation rate, plasmatic
LDH or BUN were not remarkable and hyponatremia was anec-
dotal (Table 3). Of interest is that lymphopenia and C-reactive
protein (CRP) ≥ 100 mg/L were frequent ﬁndings.
b r a z j i n f e c t d i s . 2 0 1 
Table 4 – Management and outcomes among 32 patients
with human rhinovirus-associated respiratory infection
during year 2012.
Variable Results
Place of hospitalization, n (%)
General ward 22 (68.8%)
Intermediate care 9 (28.1%)
Intensive care 1 (3.1%)
Ventilatory support
Non-invasive mechanical ventilation, n (%) 6 (18.8%)
Treatment, n (%)
Systemic corticoids 19 (59.4%)
Inhaled corticoids 11 (34.4%)
Antibiotics 29 (90.6%)
Antivirals (oseltamivir) 21 (65.6%)
Hospital length
Mean (range) in days 11.8 (2–49)
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Fourth, clinical manifestations were variable and mod-≥7 days, n (%) 20 (62.5%)
Deceased, n (%) 4 (12.5%)
No other viral agent was detected in any of these patients
y RT-PCR. Blood cultures were taken in nine patients (28.1%)
ithout demonstrating pathogenic microorganisms and two
ases presented urinary pneumococcal antigen detection
6.2%), one of them with hypotension and a CURB-65 score
f 4.
maging  studies
nterstitial (n = 8; 25%), consolidated (n = 6; 18.8%), and mixed
n = 8; 25%) patterns were observed in chest X-ray and one-
hird had normal imaging (n = 10; 31.3%). Pleural effusion was
lso recorded (n = 8; 25%).
anagement  and  outcome
en patients (31.2%) were transferred to an intermediate
are unit (n = 9) or coronary unit (n = 1) (Table 4). Six patients
equired non-invasive mechanical support. In addition, one
atient evolved with acute lung edema secondary to heart
ailure. Antibiotic and oseltamivir use were frequent (Table 4).
our patients died (in-hospital mortality 12.5%). Mean length
f stay (LOS) was 8.3 days (range 1 to 24) and over 60% remained
n the hospital more  than a week (Table 4).
everity  scores  and  risk  factors  for  mortality
 CURB-65 score < 2 points was present in 43.7% of the pop-
lation (n = 14), a value considered as cutoff for ambulatory
anagement. For the whole group, the only factor associated
o mortality was a CURB 65 score ≥3 (OR 23.4; 95% CI 1.11–489,
 < 0.05 by bilateral Fisher’s test) but was not signiﬁcant among
he 22 patients with pneumonia. The area under the curve
AUC) obtained by the Receiver Operator Curve (ROC) to pre-
ict in-hospital mortality by the CURB-65 score was 0.799 (95%
I 0.650–0.948) (Fig. 2A) and 0.813 (95% CI 0.626–0.999) for the
ubgroup with pneumonia, a value that was not signiﬁcantly
ifferent (Fig. 2B). Using a cutoff score ≥3 points to predict
ortality, sensitivity was 100% and speciﬁcity 71.4%. A cutoff5;1 9(2):118–124 121
score for the subgroup with pneumonia was not possible to
determinate due to the small number of patients deceased
with this condition (n = 2). The AUC for the CAP-PIRO score
was 0.509 demonstrating futility to predict mortality (Fig. 2A).
Deceased patients were not associated with pneumococcal
infection and two of them did not have pneumonia on the
chest X-ray.
Discussion
HRV has been progressively recognized as one of the leading
causes of acute respiratory infections among adults patients in
ambulatory11,12,23,24 or in-patient settings.3,25–27 Its frequency
may surpass other viral agents as a cause of respiratory
infections.12 Admissions by HRV infection are associated with
asthmatic crisis, chronic medical conditions, malignancies, or
immunosuppression,11,28–32 and occurs during the inﬂuenza
season as beyond this timeframe.16 In addition, HRV has
been associated to outbreaks with an increased case-fatality
ratio.33,34 The spectrum of clinical illness in adults includes
asthma, exacerbations of chronic pulmonary obstructive,
heart failure and pneumonia.29
Detailed descriptions of adult patients affected by HRV are
scarce as the expansion of molecular techniques is recent,
besides case-mixing with other etiologies or bias toward
severely ill patients.3,13,16,23,25,27,35 In this work we aimed to
characterize seasonality and clinical features of adult patients
admitted by HRV infection during one year of active surveil-
lance. Several ﬁndings in this case series deserve comments.
First, HRV infections had a prolonged seasonality that
encompassed three quarters of the year, and represented
nearly a quarter of adult hospitalizations by SARI of a known
viral cause, underscoring its medical and pathogenic rel-
evance. Only inﬂuenza remained more  important in our
prospective study, as described previously.36 Some authors
have shown that HRV infections have the most prolonged
seasonality among viral causes of pneumonia in adults,
surpassing inﬂuenza, adenovirus, coronavirus, respiratory
syncytial virus, or parainﬂuenza.3 Second, as indicated by
others, HRV-associated hospitalization affected elderly and
frail patients with chronic comorbidities and with a past or
current history of smoking.12,33,35 Third, admissions were rel-
evant because they were prolonged, required intermediate or
intensive care resources in nearly 30% of cases, and had a case
fatality rate over 10%. This proﬁle has been described in the lit-
erature and underscores the relevance of this viral agent.3,33,34
As a way of comparison, mortality by seasonal or pandemic
inﬂuenza A is similar.3,5 The proportion of HRV infected
patients that requires hospitalization (∼2–10%) depends on
the population studied and intensity of search.3,13,25,27,35 In
addition, HRV is more  frequently encountered in symptomatic
adult patients than in controls demonstrating its pathogenic
relevance.1,2,26 All of these facts indicate that HRV infections
can no longer be considered a minor nuisance and its diag-
nostic search is justiﬁed.ulated by underlying conditions such as cardiac, neuro-
logic, or pulmonary diseases, and tobacco smoking. Some
cases present as community-acquired pneumonia or as a
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Fig. 2 – (A) ROC analysis for CURB-65 and CAP-PIRO score to predict in-hospital mortality. All patients were  included. (B) ROC
analysis for the subgroup with pneumonia.
decompensated chronic condition. Fever was not universal
and, if present, was of low grade; upper respiratory illness
was not a hallmark. Fifth, to the best of our knowledge, mor-
tality risk factors have not been described for HRV infection
in adults,3,28,30,33,34 although a high severity score has been
linked to pneumococcal co-infection.3 The higher mortality
registered for those with a CURB 65 ≥ 3 is in line with the orig-
inal report of this scoring system22 and provides evidence that
it is a suitable approach for HRV infections even when patients
do not have pneumonia. In fact, the AUC of the CURB-65 ROC
analysis for the whole group and the pneumonia subgroup did
not reveal differences, suggesting that the distinction between
patients with and without respiratory inﬁltrates is perhaps
not necessary in patients affected by HRV infections. On the
other side, despite their severity at admission, nearly 40% of
patients had a low score (<2) of CURB-65, and the speciﬁcity of
a higher score was low to predict mortality (∼70%) indicating
a limited utility as a surrogate marker of risk. CAP-PIRO score
demonstrated to be uselessness and no cutoff calculation was
attempted. The limitations observed with CURB-65 to recog-
nize patients in need of admission were probably related to the
infrequent presence of hypotension in most viral respiratory
illness and to the fact that a low digital pulse oxymetry is not
considered for risk evaluation. In this sense, the current crite-
ria adopted by the Chilean Ministry of Health together with
the Pan American Health Organization appears to be better
adapted to recognize severely ill patients affected by respira-
tory viral diseases.17
HRV infection appears associated to a wide spectrum of dis-
ease and is able to rapidly decompensate vulnerable patients
as reﬂected by the relatively short symptomatic period before
admission and the high rate of hospitalization at the ﬁrst med-
ical visit.
There are probably few distinctive clinical differences
between viral and bacterial pneumonia in adults. Lobar
condensation, leukocytosis and hyponatremia are more  fre-
quently described in patients with bacterial disease, but
overlapping is common.25,37 In accordance with these reports,
our patients were characterized by minor changes in theseparameters and with a low frequency of consolidation. On
the other hand, neutrophilia, lymphopenia and elevated
C-reactive protein (≥100 mg/L) were frequent ﬁndings in
this work. Neutrophilia has been commonly found in adult
patients hospitalized with different agents of viral pneumonia
but less frequently in inﬂuenza cases3; lymphopenia has been
described in patients with pandemic A (H1N1) inﬂuenza, SARS
and metapneumovirus infection,5,38–40 and CRP is increased in
a fraction of patients admitted with inﬂuenza.5
Unfortunately, the results of viral diagnoses were not avail-
able at the time of the study and could not be useful for
de-escalation of antibiotic therapy or to suspend antiviral
inﬂuenza therapy. Knowing of a speciﬁc viral etiology has
been on one hand associated to a reduction in antibiotic
consumption in patients with respiratory viral illness, but
on the other hand, the presence of abnormal lung ﬁndings
has prompted antibiotic continuation despite a recognized
viral infection.9 Moreover, the probability of viral-bacterial
co-infection is another modulating factor that can inﬂuence
antibiotic therapeutic decisions. Bacterial-viral co-infection
rates are variable among patients with respiratory infections
(range 4–17%)3,25,27 and before a full array of rapid diagnos-
tic techniques for etiological agents are available,15 it would
be difﬁcult to curtail or de-escalate antibiotic consumption.
An imperative effort on medical education will be necessary
because a viral diagnosis, even with normal chest X-ray, is not
considered by clinicians to be sufﬁcient to stop antibiotics.7
Emergence of antibiotic resistance and Clostridium difﬁcile are
on the verge of this diagnostic shortcoming.
Our work has some limitations that require comments.
HRV can be detected some weeks after infection and can
be ampliﬁed from respiratory samples generating a subopti-
mal  speciﬁcity.18,41 However, these are universal limitations
present across all studies, and do not invalidate the scien-
tiﬁc evidence showing similar results in different scenarios.
In addition, a systematic search for respiratory bacterial
pathogens was not carried out in our study, making possi-
ble that part of the results be explained by co-infections as
it was the case in at least two patients. We believe that this
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actor is rather secondary because some patients had negative
lood cultures and the reported frequency of viral-bacterial
o-infection is not high in the literature (<20%).36 On the other
and, no viral-viral co-infection could be demonstrated in our
atients making our ﬁndings unbiased by the contribution
f other viral respiratory agents. The frequency of viral-viral
o-infection appears to be low in adults with respiratory infec-
ions (<10%).36 Finally, the results of this work were derived
rom stringent criteria for severity and they do not necessarily
epresent cases with mild disease.
onclusions
his work provides further evidence that HRV is an important
espiratory pathogen among patients admitted with SARI not
nly due to its relatively high frequency but also because HRV
nfections are able to tumble vulnerable adult patients asso-
iated to a wide spectrum of illness, using up intermediate
r critical care resources, and sometimes associated with pro-
onged hospitalization or death. In addition, the absence of a
imely diagnosis for HRV and other viral respiratory pathogens
s contributing to an inappropriate antibiotic use.
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